Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.55 |
| ▸ | SLC6A4 known ✓ | P31645 | 1/20 | 0.55 |
| ▸ | HTR6 known ✓ | P50406 | 1/20 | 0.55 |
| ▸ | DRD2 known ✓ | P14416 | 8/20 | 0.55 |
| ▸ | DRD4 known ✓ | P21917 | 8/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | QDPR | P09417 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1078756 | 1.00 | KDM4E (0.55) | KDM4ELMNAPOLBHTR1AALOX15 | |
| SCHEMBL29387382 | 1.00 | KDM4E (0.55) | KDM4ELMNAPOLBHTR1AALOX15 | |
| SCHEMBL4159466 | 0.81 | KDM4E (0.54) | KDM4ELMNAPOLBHTR1AALOX15 | |
| Hydrochloric Acid SCHEMBL1148906 | 0.79 | QDPR (0.65) | KDM4ELMNAPOLBHTR1AALOX15 | |
| SCHEMBL13999795 | 0.79 | L3MBTL1 (0.40) | KDM4ELMNAPOLBHTR1AALOX15 | |
| SCHEMBL7255363 | 0.78 | HTR6 (0.58) | KDM4ELMNAPOLBHTR1AALOX15 | |
| SCHEMBL5547709 | 0.78 | QDPR (0.54) | KDM4ELMNAPOLBHTR1AALOX15 | |
| SCHEMBL9536817 | 0.78 | DRD2 (0.48) | KDM4ELMNAHTR1AALOX15DRD2 | |
| SCHEMBL10576624 | 0.78 | DRD2 (0.48) | KDM4ELMNAHTR1AALOX15L3MBTL1 | |
| SCHEMBL11194461 | 0.78 | HTR6 (0.54) | KDM4ELMNAPOLBHTR1AALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250032557-A1 | Novel Strain Having Antagonism Against Proteus Mirabilis and Excellent Effect on Neurodegenerative Disease, and use Thereof | METACEN THERAPEUTICS CO., LTD (KR) | 2025-01-30 | — | — | US | disclosed |
| EP-4420667-A1 | NOVEL STRAIN HAVING ANTAGONISM AGAINST PROTEUS MIRABILIS AND EXCELLENT EFFECT ON NEURODEGENERATIVE DISEASE, AND USE THEREOF | Metacen Therapeutics Co., Ltd (KR) | 2024-08-28 | — | — | EP | disclosed |
| WO-2023068819-A1 | NOVEL STRAIN HAVING ANTAGONISM AGAINST PROTEUS MIRABILIS AND EXCELLENT EFFECT ON NEURODEGENERATIVE DISEASE, AND USE THEREOF | 주식회사 메타센테라퓨틱스 | 2023-04-27 | — | — | WO | disclosed |
| US-10322209-B2 | Polyurethanes for osteoimplants | WARSAW ORTHOPEDIC, INC. (US) | 2019-06-18 | — | — | US | disclosed |
| US-20180250442-A1 | POLYURETHANES FOR OSTEOIMPLANTS | WARSAW ORTHOPEDIC INC (US) | 2018-09-06 | — | — | US | disclosed |
| EP-1434608-B1 | IMPROVED BONE GRAFT | WARSAW ORTHOPEDIC INC (US) | 2018-08-22 | — | — | EP | disclosed |
| US-9993579-B2 | Polyurethanes for osteoimplants | WARSAW ORTHOPEDIC, INC. (US) | 2018-06-12 | — | — | US | disclosed |
| US-20170304496-A1 | POLYURETHANES FOR OSTEOIMPLANTS | WARSAW ORTHOPEDIC INC (US) | 2017-10-26 | — | — | US | disclosed |
| US-9789223-B2 | Polyurethanes for osteoimplants | WARSAW ORTHOPEDIC, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| US-20170240698-A1 | Biodegradable Stealth Polymeric Particles Fabricated Using The Macromonomer Approach By Free Radical Dispersion Polymerization | HOWARD UNIVERSITY (US) | 2017-08-24 | — | — | US | disclosed |
| WO-1998016209-A9 | BIOCERAMIC COMPOSITIONS | — | 1998-08-13 | — | — | WO | disclosed |
| WO-1998016209-A2 | BIOCERAMIC COMPOSITIONS | ETEX CORPORATION (US) | 1998-04-23 | — | — | WO | disclosed |
| EP-0832151-A2 | RESPONSIVE POLYMER NETWORKS AND METHODS OF THEIR USE | Gel Sciences, Inc. (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5674521-A | DRUG DELIVERY SYSTEM COMPRISING POLYMER GEL NETWORK INCLUDING BIOLOGICALLY ACTIVE SOLUTE, SALT, LOADING POLYMER; REDUCED LOSS OF ACTIVITY | UNIVERSITY OF CINCINNATI (US) | 1997-10-07 | — | — | US | disclosed |
| US-5603955-A | GEL NETWORK; PROTECTIVE POLYMER; PROTECTANT SALT | UNIVERSITY OF CINCINNATI (US) | 1997-02-18 | — | — | US | disclosed |
| WO-1997000275-A2 | RESPONSIVE POLYMER NETWORKS AND METHODS OF THEIR USE | GEL SCIENCES, INC. (US) | 1997-01-03 | — | — | WO | disclosed |
| WO-1996002239-A2 | ENHANCED LOADING OF SOLUTES INTO POLYMER GELS AND METHODS OF USE | UNIVERSITY OF CINCINNATI (US) | 1996-02-01 | — | — | WO | disclosed |
| EP-0584220-A1 | ENGINEERING THE LOCAL INFLAMMATORY RESPONSE AS A MEANS OF CONTROLLED RELEASE DRUG DELIVERY | ENDOCON, INC. (US) | 1994-03-02 | — | — | EP | disclosed |
| WO-1993023012-A1 | LIQUID-CONTAINING DRUG DELIVERY SYSTEM | ENDOCON, INC. (US) | 1993-11-25 | — | — | WO | disclosed |
| WO-1992020325-A1 | ENGINEERING THE LOCAL INFLAMMATORY RESPONSE AS A MEANS OF CONTROLLED RELEASE DRUG DELIVERY | ENDOCON, INC. (US) | 1992-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170240698-A1 | Biodegradable Stealth Polymeric Particles Fabricated Using The Macromonomer Approach By Free Radical Dispersion Polymerization | LDHA, LDHB, ALDH2 | HTR1A 2440/4885SLC6A4 3047/4885HTR6 2848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.